ArticleFrontiers in immunology2021

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma.

Deming Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.